Precancerous Lesions: Timing and Biology
|
|
- Patrick Simmons
- 6 years ago
- Views:
Transcription
1 February 3-5, 2016 Lansdowne Resort, Leesburg, VA Precancerous Lesions: Timing and Biology Victoria Seewaldt, M.D. City of Hope, Comprehensive Cancer Center, Beckman Institute
2 Early detection/prevention cancers w/ aggressive biology 18 FDG PET First pass 3T MRI Frequency BRCA1 mt - 60% Ashkenazi - 53% European American - 29% Hispanic American - 23% Asian - 20% African American Greenup et al. Ann Surg Onc
3
4 PART 1 - One-size-all screening PART 2 - If you don t know what s broke its hard to fix it. PART 3 Prevention needs to make the whole body healthy
5 PART 1 - One-size-all screening fails
6 Failure of one-size-fits-all cancer screening
7 mammography Need tothinking use the about right tool for the job anatomy1.gif (GIF Image, pixels) Mammary Fat Mammary Fat A Lactiferous Duct ER+ breast cancer Calcifications - 79% HER2+ breast cancers Calcifications - 71% Subcutaneous Fat Subareolar Musculature B Epithelial cells A Lactiferous Duct Intralobular Connective Tissue Intralobular Connective Tissue Subcutaneous Fat Subareolar Musculature Lobe Adipose cells Triple-negative breast cancers Low frequency calcs - 15% No findings - 30% Mass/Focal asymmetry - 32% B Epithelial cells Stromal collagen Stromal Fibroblasts Adipose cells Endothelial cells Endothelial cells Basement Membrane Lobe Basement Membrane Stromal collagen Stromal Fibroblasts
8 Breast MRI in Underserved Durham Women 621 premenopausal high-risk women African American Caucasian 48 mos observation, 51 breast cancers - 22 Focal / Age shifted - 29 Non-focal / Accelerated 2005 S. Riley 0 mos 36 mos 48 mos ER/PR+ T1N0 Focal, non-accelerated 22/51 women
9
10
11 BRCA1 mutation 6 mos LN metastasis 09/2010 NL tissue 02/ cm 0.1 cm 0.4 cm 0.3 cm TNBC 2+LN
12 Age Shifted Accelerated (Interval TNBC BRCA1) Genomic instability Abnormal MRI Normal Bx TNBC Node + CHEMO PALPABLE TNBC Node + CHEMO 0 mos MRI 6 mos MRI 12 mos MRI Metastasis Multi-Focal 6 month screening interval NOT sufficient
13 PART 2 - If you don t know what s broke its hard to fix it. Dad
14 DU-268L DU-266L DU-295R DU-229.2L DU-256L DU-252L DU-294L DU-292R DU-277R DU-267R DU-168.5R DU-238.2L DU-228.3L DU-221.3R DU-254R DU-247R DU-255L DU-288R DU-280L DU-39.5L DU-96.5R DU-39.5R DU-287R DU-287L DU-258L DU-290R DU-249R DU-248L DU-248R DU-249L DU-238.2R ErbB3_Y1289 PKCpanBII.S660 pikb.s32.36 Paxillin.Y118 Vimentin IGF1R.IR_Y p70s6k.t389 ErbB3 pchk1.s345 p90.rsk.s380 Stat3 mtor.s2448 pacc.s79 patpcl.s454 p38mapkinase_t180.y182 X zeta..gamma..eta E.Cadherin perk.1.2.t202.y204 EGFR pcreb.s133 IGF1R.IR.YY.YY HIF1_alpha GSK2ab.S21.9 pgsk3.alpha.beta.y279.y216 pb.catenin.t41.s45 pakt.s473 MEK1.2.S217.S221 pegfr.y1068 ErbB2 cl.casp.7.d198 Bcl.xL VEGFR2 Bad PTEN pbad.s136 Bax pegfr.y1148 pstat3.s727 ppten.s380 pbcl2.s70 pirs1.s612 pret.y905 pvegfr2.y951 Src_Y416 p53.s15 prasgrf1.s916 ER.alpha cl.casp3.d175 Akt pnfkappa.bs536 pegfr.y992 peif4g.s1108 Alternative trial design with surrogate endpoint HIGH RISK YES ATYPIA R A N D O M I Z E YES AGENT n = 300 Time = 6-12 mos NO AGENT YES or NO ATYPIA Compare Signaling Networks
15 U01CA189283: City of Hope, Duke, Ohio State, U. Tennessee, U. Wisconsin, Emory - Combined MRI/proteomic profiling Combined Cohort n=2,1070; Preliminary Data Duke n=1,241/year Normal MRI (81% n=1005 ) MRI in 12 months Abnormal Screening MRI (19% n= 236 ) Abnormal Biopsy (2% n= 24) Normal Biopsy (6% n=76) 6 week MRI No Biopsy (11% n=133) Standard-of-Care Follow up MRI 6 months 37% African American 60% Caucasian 3% Other Normal MRI women/yr Interval Cancer % 5-7 women/yr
16 Cohort n Biopsy (6%) Abn. Biopsy (2%) Interval CA (0.5%) 36 months biopsy 36 months abn. biopsy 36 months Interval CA Duke + OSU U01 Cohort U01+ NCOR Core biopsy FFPE proteomic profiling stroma/epithelium RPPA (40-60 proteins) MALDI-TOFF MS Distal core biopsy (adipose, immune cell) WBC DNA Genetic analysis Serum for cell free analysis (exosomes)
17
18 Multidisciplinary Breast Mapping REFERENCE & MARKERS& Chris Sistrunk PhD DU-429 SLICE M 5 6 L DU-390 DU-468
19 Multi-Scale Modeling/Lineage Tracing of TNBC initiation SLICE SLICE REFERENCE & MARKERS& 6 U01CA189283: City of Hope, Duke, Ohio State, U. Tennessee, U. Wisconsin, Emory Dietze, Seewaldt Nature Reviews, 2015
20 PART 3 Prevention needs to make the whole body healthy
21 From female mortality increased in >50% of US counties vs. 3% counties for men - David Kindig and Erika Cheng, University of Wisconsin - Chris Murray, University of Washington
22 Obesity and insulin resistance Diabetes occurs when the pancreas burns out Insulin glucose Healthy HgbA1C = hr glucose glucose Insulin 2 hr Resistant HgbA1C = Insulin Diabetes HgbA1C > hr
23 Woman: Pre-Diabetic Insulin resistance, produces high insulin 18 FDG PET + + At risk breast tissue Increased insulin sensitivity Obesity is a risk factor TNBC Insulin stimulates signaling pathways that promotes the aggressive behavior of TNBC
24 Conclusions: One-size-all screening fails Need to understand the biology of cancer initiation. Prevention needs to make people healthier.
25 Thank you. 1R01CA A1 1R01CA U01CA A1
26
27 Mammographic density does not predict risk for individuals - only populations Model AUC (Cecchini) AUC (Chen) AUC (Tice) AUC (Barlow) Gail Gail + density Density GREEN LINE= No better than a coin flip Gail + Density Gail Density [Cecchini et al. Boyd Can. Prev. Res. 5(11), , 2012]
28 Mammographic Density and Individual Risk
Victoria Seewaldt, M.D. Duke University
A211102 Testing for Atypia in Random Periareolar Fine Needle Aspiration (RPFNA) Cytology after 12 months Metformin Chemoprevention versus Placebo Control Victoria Seewaldt, M.D. Duke University Pre-registration
More informationTriple-Negative Breast Cancer
June 2017 Triple-Negative Breast Cancer Amir Sonnenblick, MD, PhD Sharett institute of oncology Hadassah-Hebrew university medical center, Jerusalem, Israel This presentation is the intellectual property
More informationTriple Negative Breast Cancer
Triple Negative Breast Cancer Prof. Dr. Pornchai O-charoenrat Division of Head-Neck & Breast Surgery Department of Surgery Faculty of Medicine Siriraj Hospital Breast Cancer Classification Traditional
More informationLinking Oncotype Dx results to SEER data and patient report to assess challenges in individualizing breast cancer care
Linking Oncotype Dx results to SEER data and patient report to assess challenges in individualizing breast cancer care June 16, 2015 NAACCR, Charlotte, NC Ann Hamilton, Ph.D. Keck School of Medicine, University
More informationBreast Cancer. Dr. Andres Wiernik 2017
Breast Cancer Dr. Andres Wiernik 2017 Agenda: The Facts! (Epidemiology/Risk Factors) Biological Classification/Phenotypes of Breast Cancer Treatment approach Local Systemic Agenda: The Facts! (Epidemiology/Risk
More informationChapter 2 The Link Between Obesity and Breast Cancer Risk: Epidemiological Evidence
Chapter 2 The Link Between Obesity and Breast Cancer Risk: Epidemiological Evidence 2.1 BMI and Breast Cancer Risk BMI is routinely used to qualify an individual s adiposity, yet it is simply a measure
More informationBreast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined
Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women Mortality rates though have declined 1 in 8 women will develop breast cancer Breast Cancer Breast cancer increases
More informationMaram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine
Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine The most common non-skin malignancy of women 2 nd most common cause of cancer deaths in women, following
More informationBreast Cancer. Saima Saeed MD
Breast Cancer Saima Saeed MD Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women 1 in 8 women will develop breast cancer Incidence/mortality rates have declined Breast
More informationTreatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea
Treatment options for the precancerous Atypical Breast lesions Prof. YOUNG-JIN SUH The Catholic University of Korea Not so benign lesions? Imaging abnormalities(10% recall) lead to diagnostic evaluation,
More information04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA
Intraductal Papillary Neoplasms Of Breast Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head The University of Texas MD Anderson Cancer Center 25 th Annual Seminar in Pathology Pittsburgh,
More informationUpdate in Breast Cancer Screening
Disclosure information: Update in Breast Cancer Screening Karla Kerlikowske, MDDis Update in Breast Cancer Screening Grant/Research support from: National Cancer Institute - and - Karla Kerlikowske, MD
More informationRisk Assessment, Genetics, and Prevention
Risk Assessment, Genetics, and Prevention Katherine D. Crew, MD MS Director, Clinical Breast Cancer Prevention Program Columbia University Medical Center 1 Outline Breast cancer risk factors Hereditary
More informationHost Factors that Increase Breast Cancer Risk
Host Factors that Increase Breast Cancer Risk 30 th Annual Miami Breast Cancer Conference March 7-10, 2013 Debu Tripathy, MD Professor of Medicine University of Southern California Norris Comprehensive
More informationTargeting the PI3K-Akt-mTOR pathway with GDC-0068, a novel selective ATP competitive Akt inhibitor
Targeting the PI3K-Akt-mTOR pathway with GDC-0068, a novel selective ATP competitive Akt inhibitor Josep Tabernero, Andrés Cervantes, Cristina Saura, Desamparados Roda, Yibing Yan, Kui Lin, Sumati Murli,
More informationBreast Imaging! Ravi Adhikary, MD!
Breast Imaging! Ravi Adhikary, MD! ACS Estimated Cancers Statistics 2014! Breast! New Cases in Women! 232,670 (+67,570 in situ)! Deaths in Women! 40,000! Colon! 48,380! 24,040! Cervical! 12,360! 4,020!
More informationSIGNIFICANT OTHERS. Miscellaneous Benign Breast Conditions
SIGNIFICANT OTHERS Miscellaneous Benign Breast Conditions Epworth HealthCare 1 FAT NECROSIS TRAUMATIC Cell rupture Seat-Belt injury Blunt trauma Iatrogenic injury Surgery, Flaps, Radiotherapy Pathology
More informationMousa. Israa Ayed. Abdullah AlZibdeh. 0 P a g e
1 Mousa Israa Ayed Abdullah AlZibdeh 0 P a g e Breast pathology The basic histological units of the breast are called lobules, which are composed of glandular epithelial cells (luminal cells) resting on
More informationCLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES
Papillomas. Papillomas are composed of multiple branching fibrovascular cores, each having a connective tissue axis lined by luminal and myoepithelial cells ( Fig. 23-11 ). Growth occurs within a dilated
More informationBreast Cancer Screening and High Risk
Breast Cancer Screening and High Risk Mary Freyvogel, DO Breast Surgeon Clinical Assistant Professor of Surgery University Hospitals Case Medical Center St. John Medical Center / Elyria Medical Center
More informationBreast cancer staging update. Ekaterini Tsiapali, MD, FACS MedStar Regional Breast Program Site Director
Breast cancer staging update Ekaterini Tsiapali, MD, FACS MedStar Regional Breast Program Site Director 1 1 Review of the AJCC 8 th edition breast cancer staging Review of genomic assays as stage modifiers
More informationPromise of a beautiful day
Promise of a beautiful day Ductal carcinoma in Situ Lobular Carcinoma in Situ Natural History Manosmed Tartous Oct 2009 Gérard ABADJIAN MD Pathology Department Hôtel-Dieu de France. Associate Professor
More informationElena Martinez, PhD & Bernard Futscher, PhD (co-pis) University of Arizona Arizona Cancer Center 1U01CA153086
Elena Martinez, PhD & Bernard Futscher, PhD (co-pis) University of Arizona Arizona Cancer Center 1U01CA153086 Hispanic population in U.S. is largely underserved and underrepresented in research studies
More informationCase 1. BREAST CANCER From Diagnosis to Treatment: The Role of Primary Care
BREAST CANCER From Diagnosis to Treatment: The Role of Primary Care Leah Karliner, MD MAS University of California San Francisco Primary Care Medicine Update 2009 April 2009 Case 1 AR, a 60 year old African
More informationSYSTEMIC THERAPY OPTIONS FOR BREAST CANCER IN 2014
SYSTEMIC THERAPY OPTIONS FOR BREAST Oncology Day 2014 CANCER IN 2014 Dr. Katherine Enright, M.D., M.P.H., F.R.C.P.(C) Katherine.enright@Trilliumhealthpartners.ca OBJECTIVES 1. Outline an approach to the
More informationBREAST PATHOLOGY. Fibrocystic Changes
BREAST PATHOLOGY Lesions of the breast are very common, and they present as palpable, sometimes painful, nodules or masses. Most of these lesions are benign. Breast cancer is the 2 nd most common cause
More informationBreast Cancer Risk Assessment and Prevention
Breast Cancer Risk Assessment and Prevention Katherine B. Lee, MD, FACP October 4, 2017 STATISTICS More than 252,000 cases of breast cancer will be diagnosed this year alone. About 40,000 women will die
More informationImaging the Symptomatic Patient. Avice M.O Connell MD,FACR,FSBI Professor of Imaging Sciences Director, Women s Imaging University of Rochester
Imaging the Symptomatic Patient Avice M.O Connell MD,FACR,FSBI Professor of Imaging Sciences Director, Women s Imaging University of Rochester The four most common symptoms Mass Pain Discharge Infection
More informationIncreased Risk of Breast Cancer: Screening and Prevention. Elizabeth Pritchard, MD 4/5/2017
Increased Risk of Breast Cancer: Screening and Prevention Elizabeth Pritchard, MD 4/5/2017 No disclosures Defining Risk Risk Factors Modifiable Lifestyle obesity physical activity alcohol consumption breast
More informationUnderstanding and Optimizing Treatment of Triple Negative Breast Cancer
Understanding and Optimizing Treatment of Triple Negative Breast Cancer Edith Peterson Mitchell, MD, FACP Clinical Professor of Medicine and Medical Oncology Program Leader, Gastrointestinal Oncology Department
More informationContemporary Classification of Breast Cancer
Contemporary Classification of Breast Cancer Laura C. Collins, M.D. Vice Chair of Anatomic Pathology Professor of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Outline
More informationBreast Evaluation & Management Guidelines
Breast Evaluation & Management Guidelines Pamela L. Kurtzhals, M.D. F.A.C.S. Head, Dept. of General Surgery Scripps Clinic, La Jolla Objective Review screening & diagnostic guidelines Focused patient complaints
More informationUpdate in Breast Cancer Screening
Disclosure information: Update in Breast Cancer Screening Karla Kerlikowske, MDDis Update in Breast Cancer Screening Grant/Research support from: National Cancer Institute and Grail - and - Karla Kerlikowske,
More informationConservative Surgery and Radiation Stage I and II Breast Cancer
Conservative Surgery and Radiation Stage I and II Breast Cancer Variant 1: Premenopausal 41-year-old woman, 1.1-cm GII IDC, upper outer quadrant (UOQ), ER/PR ( ), HER2 ( ), primary excised with lumpectomy,
More informationBreast Cancer Basics. Clinical Oncology for Public Health Professionals. Ben Ho Park, MD, PhD
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationHEALTH CARE DISPARITIES. Bhuvana Ramaswamy MD MRCP The Ohio State University Comprehensive Cancer Center
HEALTH CARE DISPARITIES Bhuvana Ramaswamy MD MRCP The Ohio State University Comprehensive Cancer Center Goals Understand the epidemiology of breast cancer Understand the broad management of breast cancer
More informationDiseases of the breast (2 of 2) Breast cancer
Diseases of the breast (2 of 2) Breast cancer Epidemiology & etiology The most common type of cancer & the 2 nd most common cause of cancer death in women 1 of 8 women in USA Affects 7% of women Peak at
More informationBreast Cancer. Excess Estrogen Exposure. Alcohol use + Pytoestrogens? Abortion. Infertility treatment?
Breast Cancer Breast Cancer Excess Estrogen Exposure Nulliparity or late pregnancy + Early menarche + Late menopause + Cystic ovarian disease + External estrogens exposure + Breast Cancer Excess Estrogen
More informationElectra D. Paskett, Ph.D. The Ohio State University Multi-level Approaches to Addressing Cancer Disparities
Electra D. Paskett, Ph.D. The Ohio State University Multi-level Approaches to Addressing Cancer Disparities February 3-5, 2016 Lansdowne Resort, Leesburg, VA Models to Understand and Address Disparities
More informationLayered-IHC (L-IHC): A novel and robust approach to multiplexed immunohistochemistry So many markers and so little tissue
Page 1 The need for multiplex detection of tissue biomarkers. There is a constant and growing demand for increased biomarker analysis in human tissue specimens. Analysis of tissue biomarkers is key to
More informationRecent advances in breast cancers
Recent advances in breast cancers Breast cancer is a hetrogenous disease due to distinct genetic alterations. Similar morphological subtypes show variation in clinical behaviour especially in response
More informationYong Wu, Ph.D. Division of Cancer Research and Training (DCRT) Charles R. Drew University of Medicine & Science
Yong Wu, Ph.D. Division of Cancer Research and Training (DCRT) Charles R. Drew University of Medicine & Science Jay Vadgama, Ph.D Chief, Division of Cancer Research and Training Background One in 8 women
More informationImaging Guidelines for Breast Cancer Screening
Imaging Guidelines for Breast Cancer Screening Sarah Colwick, MD Dr. Sarah Colwick was born and raised in Sikeston, MO. She attended college and medical school at the University of Missouri-Kansas City
More informationMRI-Based Biomarkers of Therapeutic Response in Triple-Negative Breast Cancer
MRI-Based Biomarkers of Therapeutic Response in Triple-Negative Breast Cancer Daniel Golden Postdoctoral Scholar (Radiology) Stanford University Daniel Rubin Laboratory NCI Cancer Imaging Fellowship Seminar
More informationUnderstanding PI3K/mTOR/MEK signalling in breast cancer. Euphemia Leung Auckland Cancer Society Research Centre University of Auckland
Understanding PI3K/mTOR/MEK signalling in breast cancer Euphemia Leung Auckland Cancer Society Research Centre University of Auckland Receptor status of human breast cancer On a popula>on basis ER+/PR+
More informationBREAST SURGERY PROGRESS TEST Name:
General Surgery Residency Program Excellent surgeons BREAST SURGERY PROGRESS TEST Name: Choose the BEST answer for the following questions. 1. All of the following factors are associated with an increased
More informationCurrent Status of Supplementary Screening With Breast Ultrasound
Current Status of Supplementary Screening With Breast Ultrasound Stephen A. Feig, M.D., FACR Fong and Jean Tsai Professor of Women s Imaging Department of Radiologic Sciences University of California,
More informationScreening Mammography: The Controversy, Risk Assessment and Individualized Screening recommendations. Jonathan T. Sims MD, MBA
Screening Mammography: The Controversy, Risk Assessment and Individualized Screening recommendations. Jonathan T. Sims MD, MBA I have no relevant Financial Disclosures Agenda Discuss the recent studies
More informationLearning Objectives. ! At the end of the presentation,students will be able to:
Learning Objectives! At the end of the presentation,students will be able to: Define Breast Cancer Identify the controllable and uncontrollable risk factors of breast cancer Recognize the 4 stages of breast
More information04/10/2018 HIGH RISK BREAST LESIONS. Pathology Perspectives of High Risk Breast Lesions ELEVATED RISK OF BREAST CANCER HISTORICAL PERSPECTIVES
Pathology Perspectives of High Risk Breast Lesions Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head Director of Clinical Trials, Research and Development The University of Texas MD
More informationLYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR
BREAST LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR HISTOLOGY LOBE: (10 in whole breast) LOBULE: (many per lobe) ACINUS/I, aka ALVEOLUS/I: (many per lobule) DUCT(S): INTRA- or
More informationBreast Cancer: Current Approaches to Diagnosis and Treatment
Breast Cancer: Current Approaches to Diagnosis and Treatment Barbara L. Smith, MD, Ph.D. Massachusetts General Hospital Division of Surgical Oncology No Disclosures Incidence of Breast Cancer USA 2018
More informationHealth Disparities Advances in Breast Cancer Treatment. Jo Anne Zujewski April 27, 2009
Health Disparities Advances in Breast Cancer Treatment Jo Anne Zujewski April 27, 2009 Disclaimer Breast Cancer Incidence 1994-2003 Breast Cancer Mortality 1994-2003 Access to Care Comorbidity Biology
More informationMANAGEMENT OF DENSE BREASTS. Nichole K Ingalls, MD, MPH NW Surgical Specialists September 25, 2015
MANAGEMENT OF DENSE BREASTS Nichole K Ingalls, MD, MPH NW Surgical Specialists September 25, 2015 No financial disclosures National Cancer Institute National Cancer Institute Increased Cancer Risk... DENSITY
More informationEvaluations & CE Credits
Evaluations & CE Credits Nursing Contact Hours, CME and CHES credits are available. Please visit www.phlive.org to fill out your evaluation and complete the post-test. 1 Breast Density and Breast Cancer
More informationLooking Beyond the Standard-of- Care : The Clinical Trial Option
1 Looking Beyond the Standard-of- Care : The Clinical Trial Option Terry Mamounas, M.D., M.P.H., F.A.C.S. Medical Director, Comprehensive Breast Program UF Health Cancer Center at Orlando Health Professor
More informationThe Genetics of Breast and Ovarian Cancer Prof. Piri L. Welcsh
The Genetics of Breast Piri L. Welcsh, PhD Research Assistant Professor University of Washington School of Medicine Division of Medical Genetics 1 Genetics of cancer All cancers arise from genetic and
More informationBREAST CANCER. Dawn Hershman, MD MS. Medicine and Epidemiology Co-Director, Breast Program HICCC Columbia University Medical Center.
BREAST CANCER Dawn Hershman, MD MS Florence Irving Assistant Professor of Medicine and Epidemiology Co-Director, Breast Program HICCC Columbia University Medical Center Background Breast cancer is the
More informationCPC 4 Breast Cancer. Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast.
CPC 4 Breast Cancer Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast. 1. What are the most likely diagnoses of this lump? Fibroadenoma
More informationFundamental research on breast cancer in Belgium. Rosita Winkler
Fundamental research on breast cancer in Belgium Rosita Winkler Medline search for «breast cancer» and Belgium limits: english, posted in the last 5 years. Result: 484 papers - fundamental / clinical -
More informationBreast Cancer: Key Issues for the Non-Oncologist
Breast Cancer: Key Issues for the Non-Oncologist I have no financial disclosures I developed and validated one of the models that will be discussed. I hold no patents and derive no financial benefit from
More informationChapter 28. Breasts and Mammary Glands
Chapter 28 Breasts and Mammary Glands Breasts and Mammary Glands breast mound of tissue overlying the pectoralis major enlarges at puberty and remains so for life most of the time it contains very little
More informationBreast Cancer Imaging
Breast Cancer Imaging I. Policy University Health Alliance (UHA) will cover breast imaging when such services meet the medical criteria guidelines (subject to limitations and exclusions) indicated below.
More informationQuestion 1 A. ER-, PR-, HER+ B. ER+, PR+, HER2- C. ER-, PR+, HER2- D. ER-, PR-, HER2- E. ER-, PR+, HER2+
Triple Negative Breast Cancer Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA Question 1 The tumor depicted on the next slide
More information2017 Breast Cancer Update
2017 Breast Cancer Update Alberto J Montero, M.D., MBA Quality Improvement Officer, Taussig Cancer Institute, Lerner College of Medicine Cleveland Clinic N/A Disclosure Overview Epidemiology (US/Global)
More informationBreast Cancer: Selected Topics for the Primary Care Clinician
Breast Cancer: Selected Topics for the Primary Care Clinician Leah Karliner, MD MAS October 2009 Primary Care Medicine: Principles and Practice OUTLINE Incidence and Mortality Risk Factors and Risk Reduction/Prevention
More informationCan We Omit Surgery with Suggestion of pcr by Biopsy in Breast? Fudan University Shanghai Cancer Center Ke-Da Yu, M.D.
Can We Omit Surgery with Suggestion of pcr by Biopsy in Breast? Fudan University Shanghai Cancer Center Ke-Da Yu, M.D. I have no relevant financial relationship with commercial interests to disclose. More
More informationTriple-negative breast cancer: which typical features can we identify on conventional and MRI imaging?
Triple-negative breast cancer: which typical features can we identify on conventional and MRI imaging? Poster No.: C-1862 Congress: ECR 2013 Type: Educational Exhibit Authors: V. Bertani 1, A. Gualano
More informationManagement of Inflammatory Breast Cancer: Collaboration is the path forward
Management of Inflammatory Breast Cancer: Collaboration is the path forward Massimo Cristofanilli, M.D., F.A.C.P. Professor of Medicine Associate Director of Translational Research and Precision Medicine
More informationDifferent Types of Cancer
Different Types of Cancer Cancer can originate almost anywhere in the body. Sarcomas (connective tissue) Ø arise from cells found in the supporting tissues of the body such as bone, cartilage, fat, connective
More informationDisclosure of Relevant Financial Relationships. Breast Pathology Evening Specialty Conference Case #4. Clinical Case: Pathologic Features
Breast Pathology Evening Specialty Conference Case #4 K.P. Siziopikou, MD, PhD Professor of Pathology Director of Breast Pathology and Breast Pathology Fellowship Program Northwestern University Feinberg
More informationHealth Inequity and Controversies in Cancer Screening. Doris Browne, MD, MPH Immediate Past President, NMA September
Health Inequity and Controversies in Cancer Screening Doris Browne, MD, MPH Immediate Past President, NMA September 12 2018 DISCLOSURE In compliance with ACCME Guidelines, I hereby declare: I do not have
More informationCase Presentation and Discussion: Breast Cancer. Madhuri Rao, MD PGY-5 SUNY Downstate Medical Center
Case Presentation and Discussion: Breast Cancer Madhuri Rao, MD PGY-5 SUNY Downstate Medical Center Case Presentation 37 y/o female PMH/PSH: nil Meds: nil NKDA Family Hx: Sister died in early 30 s from
More informationInsights and Updates in Breast Cancer. No Disclosures. Learning Objectives. Mountain States Cancer Conference 2017 Regina Jeanise Brown MD
Insights and Updates in Breast Cancer Mountain States Cancer Conference 2017 Regina Jeanise Brown MD 10/14/17 No Disclosures Learning Objectives Understand screening recommendations Understand the effectiveness
More informationTriple Negative Breast cancer New treatment options arenowhere?
Triple Negative Breast cancer New treatment options arenowhere? Ofer Rotem, M.D., B.Sc. Breast Unit, Davidoff center Rabin Medical center October 2017 Case 6/2013 - M.D., 38 years old woman, healthy, no
More informationCase 1. ACCME/Disclosure. Clinical History. Dr. Mulligan has nothing to disclose
Breast Evening Specialty Conference USCAP, 2016 Case 1 Anna Marie Mulligan University Health Network, Toronto University of Toronto ACCME/Disclosure Dr. Mulligan has nothing to disclose Clinical History
More informationPAAF vs Core Biopsy en Lesiones Mamarias Case #1
5/19/2014 PAAF vs Core Biopsy en Lesiones Mamarias Case #1 Fine Needle Aspiration Cytology of Breast: Correlation with Needle Core Biopsy 64-year-old woman Mass in breast Syed Hoda, MD CD31 Post-Radiation
More informationDiseases of the breast (1 of 2)
Diseases of the breast (1 of 2) Introduction A histology introduction Normal ducts and lobules of the breast are lined by two layers of cells a layer of luminal cells overlying a second layer of myoepithelial
More informationBREAST CANCER d an BREAST SELF EXAM
BREAST CANCER and BREAST SELF EXAM American Cancer Society Statistics: 2009 Invasive breast cancer will be diagnosed in over 192,370 women Carcinoma in situ will be diagnosed in 62,280 women More than
More informationThe Dilemma of Breast Density in Screening
The Dilemma of Breast Density in Screening Priscilla J. Slanetz MD, MPH, FACR, FSBI Associate Professor of Radiology, Harvard Medical School Beth Israel Deaconess Medical Center, Boston, MA No financial
More informationSusan G. Komen Tri-Cities Quantitative Data Report
Susan G. Komen Tri-Cities Quantitative Data Report 2014 Contents 1. Purpose, Intended Use, and Summary of Findings... 4 2. Quantitative Data... 6 2.1 Data Types... 6 2.2 Breast Cancer Incidence, Death,
More informationBreast MRI: Friend or Foe?
Breast MRI: Friend or Foe? UCSF Postgraduate Course May 18, 2013 Cheryl Ewing, MD Clinical Professor of Surgery UCSF Department of Surgery APPLEGATE HAS DOUBLE MASTECTOMY IN CANCER SCARE DIAGNOSED WITH
More informationList of Available TMAs in the PRN
TMA RPCI_BrainCa01 RPCI_BrCa03 RPCI_BrCa04 RPCI_BrCa05 RPCI_BrCa0 RPCI_BrCa07 RPCI_BrCa08 RPCI_BrCa15 RPCI_BrCa1 RPCI_BrCa17 RPCI_BrCa18 RPCI_BrCa19 RPCI_BrCa20 RPCI_BrCa21 RPCI_BrCa24 RPCI_BrCa25 RPCI_BrCa2
More information6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017
Genetics 101 Hereditary Breast and Ovarian Cancer 2017 Rebecca Sutphen, MD, FACMG Professor, College of Medicine President & Chief Medical Officer INVASIVE CANCER GENETICALLY ALTERED CELL HYPERPLASIA DYSPLASIA
More informationAfternoon Session Cases
Afternoon Session Cases Case 1 19 year old woman Presented with abdominal pain to community hospital Mild incr WBC a14, 000, Hg normal, lipase 100 (normal to 75) US 5.2 x 3.7 x 4 cm mass in porta hepatis
More informationClassification System
Classification System A graduate of the Breast Oncology training program should be able to care for all aspects of disease and/or provide comprehensive management. When referring to a discipline of training
More informationBreast Imaging: Multidisciplinary Approach. Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina
Breast Imaging: Multidisciplinary Approach Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina No Disclosures Objectives Discuss a multidisciplinary breast
More informationManagement of BRCA Positive Breast Cancer. Archana Ganaraj, MD February 17, 2018 UPDATE ON WOMEN S HEALTH
Management of BRCA Positive Breast Cancer Archana Ganaraj, MD February 17, 2018 UPDATE ON WOMEN S HEALTH The number of American women who have lost their lives to breast cancer outstrips the total number
More informationAMSER Case of the Month: November 2018
AMSER Case of the Month: November 2018 52 year old female with an abnormal screening mammogram Areeg Rehman, MS 4 Nova Southeastern University Rebecca T. Sivarajah, MD Penn State University College of
More informationBreast Cancer in Young Women Arrow Project June 6 th Aharona Gutman Dr. Shani Paluch-Shimon
Breast Cancer in Young Women Arrow Project June 6 th 2013 Aharona Gutman Dr. Shani Paluch-Shimon Overview - Breast Cancer in Young Women 10% of breast cancers are diagnosed in women under 40 Breast cancer
More informationMelissa Hartman, DO Women s Health Orlando VA Medical Center
Melissa Hartman, DO Women s Health Orlando VA Medical Center Most common non-skin cancer and Second deadliest cancer in women Majority are diagnosed by abnormal screening study An approach to breast cancer
More informationMBC Connect v0.9 (150) - Sat Sep :38:56 GMT+0000 (UTC)
MBC Connect v0.9 (150) - Sat Sep 08 2018 01:38:56 GMT+0000 (UTC) Opening Screen: Demographics and general information (6-11 questions) We request information about your gender, menopausal status, race,
More informationTriple Negative Breast Cancer. Eric P. Winer, MD Dana-Farber Cancer Institute Harvard Medical School Boston, MA October, 2008
Triple Negative Breast Cancer Eric P. Winer, MD Dana-Farber Cancer Institute Harvard Medical School Boston, MA October, 2008 Triple Negative Breast Cancer 15% 25% Triple Negative 20% HER2+ ER+ Low Grade
More informationOne Breast Cancer Annual Report
One 2015 Breast Cancer Annual Report One OVERVIEW The Breast Program at Carolinas HealthCare System s Levine Cancer Institute, offers comprehensive care. Patients with benign and malignant disease of the
More informationEARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY
EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School Breast Cancer Screening Early detection of
More informationReview of adjuvant and neo-adjuvant abstracts from SABCS 2011 January 7 th 2012
Review of adjuvant and neo-adjuvant abstracts from SABCS 2011 January 7 th 2012 Ruth M. O Regan, MD Professor and Vice-Chair for Educational Affairs, Department of Hematology and Medical Oncology, Emory
More informationOne or Two Clusters of Crushed Stone like Calcifications on the Mammogram Produced by Malignancy
66 One or Two Clusters of Crushed Stone like Calcifications on the Mammogram Produced by Malignancy Example 2.13 A 36-year-old woman who recentlyfelt a small hard lump in the upper-outer quadrant of her
More informationThe Hot Topic for today is a biopsy from a 58-year-old woman who had worrisome mammographic calcifications on screening.
The Hot Topic for today is a biopsy from a 58-year-old woman who had worrisome mammographic calcifications on screening. 1 My name is Dan Visscher; I am a consultant in the Division of Anatomic Pathology
More informationThe Evolving Role of Adjuvant Therapies
Therapy-predictive markers for adjuvant chemotherapy The Evolving Role of Adjuvant Therapies Micrometastasis Prognostic Markers (BRCA1) Cured No Further Tx Chemosensitive Rafael Rosell th European Perspectives
More informationTriple Receptor Negative Breast Cancer: Imaging and Clinical Characteristics
Women s Imaging Original Research Krizmanich-Conniff et al. Triple Receptor Negative Breast Cancer Women s Imaging Original Research Kristin M. Krizmanich-Conniff 1 Chintana Paramagul 2 Stephanie K. Patterson
More information